Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients

Trabectedin and ifosfamide are among the few cytostatic agents active in advanced soft tissue sarcomas (STSs). Trabectedin is most potent against so-called L-sarcomas (leiomyosarcoma and liposarcoma). The survival gain and cost-effectiveness of these agents in a second-line setting were analysed in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Sarcoma
Main Authors: Verboom, Michiel C., Gelderblom, Hans, Kerst, J. Martijn, Steeghs, Neeltje, Reyners, Anna K. L., Sleijfer, Stefan, van der Graaf, Winette T. A., van den Hout, Wilbert B.
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi 2019
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6589299/
https://ncbi.nlm.nih.gov/pubmed/31281207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3234205
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker